Cincinnati Expands Access to Overdose Prevention Tools
Cincinnati is expanding access to Narcan and fentanyl test strips at locations identified as overdose hotspots.
Cincinnati, OH, September 16, 2026 —
Cincinnati is taking steps to increase the availability of Narcan (naloxone) and fentanyl test strips in areas identified as hotspots for overdoses.
The initiative aims to provide crucial overdose reversal medication and harm reduction tools directly to communities most affected by the ongoing opioid crisis.
Narcan is a nasal spray that can rapidly reverse the effects of an opioid overdose. Fentanyl test strips allow individuals to check if their drugs contain fentanyl, a potent synthetic opioid that has been a major driver of overdose deaths.
The expansion targets specific locations within Cincinnati that have been identified by authorities as having a high prevalence of overdose incidents. The exact locations and the specific method of expansion, such as distribution points or outreach programs, were not detailed in the provided information.
Details regarding the timeline for this expansion, the specific city department or agency leading the effort, and any partner organizations involved were not immediately available. Information on whether this represents a new program or an enhancement of existing services was also not provided.
The broader goal of such public health initiatives is typically to reduce overdose fatalities and promote safer drug use practices among vulnerable populations. The availability of these tools in targeted hotspots is a key component of harm reduction strategies employed by many municipalities addressing the opioid epidemic.
Story summarized from the original created by Google News on news.google.com, see more information here.
